Norikazu Eiki

MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts.

University of Washington functions as a College/University. The company is headquartered in Seattle, WA.

IBM Japan Ltd. engages in the provision of products and services related to information systems. The company was founded on June 17, 1937 and is headquartered in Tokyo, Japan.

Part of Towa Pharmaceutical Co., Ltd., J-Dolph Co., Ltd. is a Japanese company that manufactures and sells pharmacies. The private company is based in Koga-gun, Japan. J-Dolph Co. was acquired by Towa Pharmaceutical Co., Ltd. on October 01, 2003.

Part of ITOCHU Corp., ITOCHU CHEMICAL FRONTIER Corp. is a Japanese company that imports and markets allied chemicals. The private company is based in Tokyo, Japan.

Part of Takeda Pharmaceutical Co., Ltd., Amgen KK is a wholly owned Japanese affiliate of Amgen Inc., one of the largest independent biotechnology companies in the world. The private company is based in Tokyo, Japan. Amgen KK focuses on disease areas with significant unmet medical needs, including cardiometabolic, oncological, bone, inflammation/immune and neurological diseases. Currently, approximately 600 employees engage in activities from clinical development to sales with the mission of "to serve patients – doing everything we can now, for the patients." The Japanese company was founded by Fuminori Yoshida. Amgen KK was acquired by Takeda Pharmaceutical Co., Ltd. from Amgen, Inc. on March 31, 2008 for $16.58 million.

REGiMMUNE Corp. develops solutions for treating immune disorders. Its focus is on the discovery, development, and commercialization of immune regulatory therapeutics to treat life-threatening and debilitating conditions, including allergies, autoimmune diseases and transplantation. The firm's platform technology, reVax, induces immune tolerance in an antigen-specific manner through pharmacological induction of regulatory T (Treg) cells. It also develops products for preventing inhibitor formation in enzyme replacement therapies (ERT) and for celiac disease with undisclosed partners. The company was founded by Yasuyuki Ishii on March 3, 2006 and is headquartered in Tokyo, Japan.

PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

RRD International LLC develops biopharmaceutical products. The firm offers product development support to biotechnology, pharmaceutical and medical device companies. Its services include development, strategic planning, program management and research. The company was founded by Frank L. Hurley and Charles W. Finn in 2002 and is headquartered in Rockville, MD.

Kitahama Partners is a law firm based in Osaka, Japan. The Japanese company operates as a law firm.

Eddingpharm (Cayman) Inc. provides specialty pharmaceuticals marketing services. It focuses on medical nutrition and oncology therapeutic areas and creates a commercialization platform for pharmaceutical products. The company was founded by Xin Ni and Jiang Yao in 2001, and is headquartered in Hong Kong.

Part of Towa Pharmaceutical Co., Ltd., Daichi Kasei KK is a Japanese company that tests and manufactures intermediate medicines and chemical compounds. The private company is based in Himeji, Japan. Daichi Kasei KK was acquired by Towa Pharmaceutical Co., Ltd. from KNC Laboratories Co., Ltd. on October 19, 2010.

Part of AnGes, Inc., AnGes USA, Inc. develops and manufactures medicines. The private company is based in Gaithersburg, MD. Ei Yamada has been the CEO of the company since 2014.

Part of ITOCHU Corp., Beijing ITOCHU-Huatang Comprehensive Processing Co., Ltd. engages in general wholesale business of cosmetics, daily commodities, and sundries. The private company is based in Beijing, China.

Xi'an Libang Pharmaceutical Co. Ltd. is a private company that develops, produces, and distributes pharmaceutical products. The company is based in Xi'an, China.

Okinawa Protein Tomography Ltd. provides polymeric molecular structure analysis services. Its technology allows imaging of macromolecules including proteins in multiple states at the single molecule-level by combining conventional electron tomography and a specifically designed 3D reconstruction program known as COMET. The firm analyzes data of molecular structures of protein samples. The company was founded by Akira Kamei on June 25, 2014 and is headquartered in Uruma, Japan.

Part of Baxter International, Inc., Baxter (China) Investment Co. Ltd. provides investment services. The private company is based in Shanghai, China.

LTL Pharma Co., Ltd. is a pharmaceutical company founded in 2016 and based in Tokyo, Japan. The Japanese company specializes in long-term products and aims to provide reliable and effective products to patients. The company's website includes a product list page that is limited to medical professionals. LTL Pharma actively seeks business alliances with other companies both domestically and overseas. The company's top management greetings are also available on their website.

Oligogen, Inc. conducts research and development services for cell medicines. The company is based in Kyoto, Japan. The Japanese company was founded in 2015 by Tsuneo Kido.

Japan Regenerative Medicine Co., Ltd. engages in the research and development of regenerative medicine technology, products and cell medicine. The company was founded on October 16, 2013 and is headquartered in Tokyo, Japan.

MyBiotics Pharma Ltd. operates as a micro biome pharmaceutical company that develops live bacteria based drugs. It develops MyCrobe and SuperDonor technologies for growing specific bacterial communities on pre-selected particles for stable and resistant raw material and for multi bacterial products. The company was founded in and is headquartered in Ness Ziona, Israel.

Oriciro Genomics, Inc. develops DNA based assembly and amplification technology solutions. The company was founded in December 2018 and is headquartered in Tokyo, Japan.

Emendo Biotherapeutics, Inc. engages in the development of genome editing technology. It specializes in protein engineering, molecular biology, and gene editing systems. The company was founded by David Baram, Lior Izhar, and Rachel Diamant in 2015 and is headquartered in New York, NY.

Shenzhen Tailai Biotechnology Co., Ltd. is a Chinese company that specializes in the research and development of cancer screening products and services. The company is based in Shenzhen, China. and has subsidiaries in China. Yiu Kwan Lau has been the CEO of the company since 2018.